↓ Skip to main content

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
12 X users
patent
10 patents

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
68 Mendeley